Eledon Pharmaceuticals, Inc. (ELDN) vs Keros Therapeutics, Inc. (KROS)

Eledon Pharmaceuticals, Inc. and Keros Therapeutics, Inc. are both Biotechnology companies. Eledon Pharmaceuticals, Inc. and Keros Therapeutics, Inc. are of similar size ($229.0M and $228.3M). Across the 10 metrics below, Keros Therapeutics, Inc. leads on 9 and Eledon Pharmaceuticals, Inc. on 1.

Valuation

Metric ELDN KROS Biotechnology median
P/E n/m n/m 7.88
P/S n/m 6.97 11.47
P/B 9.16 0.88 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.26 0.74
EV/Sales n/m (0.79) 10.73
Earnings yield (34.21%) (31.68%) (28.84%)
Free cash flow yield (24.43%) (20.97%) (23.03%)

Profitability

Metric ELDN KROS Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (236.51%) (17.16%) (57.72%)
Return on assets (72.74%) (15.92%) (49.22%)
Return on invested capital 0.00% (1,345.30%) 0.00%

Growth

Metric ELDN KROS Biotechnology median
Revenue growth (TTM) — (84.55%) 5.64%
EPS growth (last fiscal year) 30.67% 146.00% —
Revenue growth, 5-year CAGR — 89.45% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELDN KROS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.90 21.96 4.73
Net debt to EBITDA 1.60 (4.16) 0.96

Dividend

Metric ELDN KROS Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ELDN KROS Biotechnology median
Market cap 228.34m 229.00m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack